AusPAR: Beyfortus
Australian Public Assessment Report
Device/Product Name
Beyfortus
Active ingredients
Nirsevimab
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-04428-1-2
Submission Type
New biological entity
Decision
Approved